TTP and aHUS in Complicated Pregnancies
NCT03605511 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 150
Last updated 2018-09-25
Summary
A single site observational study aiming to:
(i) Identify cases of previously undiagnosed thrombotic thrombocytopenic purpura (TTP) and atypical haemolytic syndrome (aHUS) in a cohort of women with complicated pregnancies (ii) Characterise the clinical features of these cases and (ii) Identify clinical features or biomarkers which may help distinguish TTP/aHUS from other complications of pregnancy such as preeclampsia
Conditions
- Thrombotic Thrombocytopenic Purpura
- Atypical Hemolytic Uremic Syndrome
- Pre-Eclampsia
- HELLP Syndrome
- Thrombocytopenia
- IUGR
- Stillbirth
- Thrombotic Microangiopathies
Interventions
- DIAGNOSTIC_TEST
-
ADAMTS 13, complement and angiogenic biomarkers
ADAMTS 13, complement and angiogenic biomarkers
Sponsors & Collaborators
-
University College, London
lead OTHER
Eligibility
- Min Age
- 16 Years
- Sex
- FEMALE
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2018-09-21
- Primary Completion
- 2020-03-14
- Completion
- 2020-03-14
Countries
- United Kingdom
Study Locations
More Related Trials
-
Thromboelastogram in Postdelivery Preeclamptic Patients
NCT03555630 ·Status: COMPLETED
-
Prospective Study in Pregnant Women With Hypercoagulopathy
NCT00215969 ·Status: UNKNOWN
-
Pilot Project Renal and Cardiovascular Tertiary Prevention in Preeclampsia
NCT07151339 ·Status: RECRUITING
-
Improved Characterisation of Eclampsia
NCT05199558 ·Status: UNKNOWN
-
Towards Routine HPA-screening In Pregnancy to Prevent FNAIT
NCT04067375 ·Status: COMPLETED
-
State of Coagulation in Pre-eclampsia: Comparing Sonoclot Signature Analysis With Conventional and Specific Haemostasis Assays
NCT05625763 ·Status: UNKNOWN
-
Genotyping of Human Platelet Alloantigens : Non-invasive Prenatal Diagnosis
NCT02899598 ·Status: WITHDRAWN ·Phase: NA
-
Immune Thrombocytopenia in Pregnancy
NCT02892630 ·Status: UNKNOWN
-
TIPPS: Thrombophilia in Pregnancy Prophylaxis Study
NCT00967382 ·Status: COMPLETED ·Phase: PHASE3
-
The Clinical Features and Pregnancy Outcomes of CTD Patients
NCT04918524 ·Status: RECRUITING
-
Pharmacokinetics of Low Molecular Weight and Unfractionated Heparin in Pregnancy
NCT00721591 ·Status: COMPLETED
-
Evaluation of Neutrophil/Lymphocyte Ratio ,Platelet/Lymphocyte Ratio and CRP as Markers of Severity of Pre-eclampsia
NCT03630276 ·Status: UNKNOWN ·Phase: NA
-
Study of Coagulation Activation Markers and Pre Eclampsia
NCT01261351 ·Status: COMPLETED
-
sCD163 in HELLP Syndrome
NCT07209748 ·Status: NOT_YET_RECRUITING
-
Thrombophilia Screening After Severe IUGR
NCT05551078 ·Status: UNKNOWN
-
New Biological Tests in Patients With Antiphospholipid Antibodies
NCT03890601 ·Status: RECRUITING
-
Predicting Late-onset Preeclampsia at 10-14 Weeks of Pregnancy
NCT04075708 ·Status: COMPLETED
-
Antiphospholipid Antibodies and Early Severe Preeclampsia.
NCT01538121 ·Status: UNKNOWN
-
The Use of Eculizumab in HELLP Syndrome
NCT04103489 ·Status: COMPLETED ·Phase: PHASE1
-
The Prognostic Value of PGF and sFlt1 Variations Induced by the First Low-molecular-weight-heparin Injections in Women With Obstetrical Antiphospholipids Antibody Syndrome Starting a New Pregnancy and Following Treatment in Accordance With International Recommendations
NCT02855047 ·Status: COMPLETED
-
Urine and Serum Concentrations of Pregnancy-Associated Compounds During Gestation
NCT03552055 ·Status: COMPLETED
-
Evaluation of the Incidence of Cancer in the Follow-up of Women With 3 Consecutive Embryonic Demises Before 10 Weeks or 1 Fetal Death, According to Their Thrombophilia Status, With a Special Focus on Women With an Obstetric Antiphospholipid Symdrome (oAPS)
NCT03969498 ·Status: COMPLETED
-
Evaluation of Pre-dose and Post-dose Anti-factor Xa Levels With Enoxaparin Use During Pregnancy
NCT00319176 ·Status: COMPLETED
-
Platelets in Pregnancy
NCT06194643 ·Status: ACTIVE_NOT_RECRUITING
-
Use of Lumella-glycosylated Fibronectin for Diagnosis of Preeclampsia
NCT06085001 ·Status: NOT_YET_RECRUITING